109 related articles for article (PubMed ID: 15278363)
1. Inhibition of melanoma metastases by fenofibrate.
Grabacka M; Placha W; Plonka PM; Pajak S; Urbanska K; Laidler P; Slominski A
Arch Dermatol Res; 2004 Jul; 296(2):54-8. PubMed ID: 15278363
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptor alpha activation decreases metastatic potential of melanoma cells in vitro via down-regulation of Akt.
Grabacka M; Plonka PM; Urbanska K; Reiss K
Clin Cancer Res; 2006 May; 12(10):3028-36. PubMed ID: 16707598
[TBL] [Abstract][Full Text] [Related]
3. Effect of peroxisome proliferator-activated receptor-alpha ligands in the interaction between adipocytes and macrophages in obese adipose tissue.
Toyoda T; Kamei Y; Kato H; Sugita S; Takeya M; Suganami T; Ogawa Y
Obesity (Silver Spring); 2008 Jun; 16(6):1199-207. PubMed ID: 18356826
[TBL] [Abstract][Full Text] [Related]
4. Effects of fenofibrate and xuezhikang on high-fat diet-induced non-alcoholic fatty liver disease.
Hong XZ; Li LD; Wu LM
Clin Exp Pharmacol Physiol; 2007; 34(1-2):27-35. PubMed ID: 17201732
[TBL] [Abstract][Full Text] [Related]
5. Lipid-lowering drugs in the MPTP mouse model of Parkinson's disease: fenofibrate has a neuroprotective effect, whereas bezafibrate and HMG-CoA reductase inhibitors do not.
Kreisler A; Gelé P; Wiart JF; Lhermitte M; Destée A; Bordet R
Brain Res; 2007 Mar; 1135(1):77-84. PubMed ID: 17196944
[TBL] [Abstract][Full Text] [Related]
6. Effects of peroxisome proliferator-activated receptor ligands, bezafibrate and fenofibrate, on adiponectin level.
Hiuge A; Tenenbaum A; Maeda N; Benderly M; Kumada M; Fisman EZ; Tanne D; Matas Z; Hibuse T; Fujita K; Nishizawa H; Adler Y; Motro M; Kihara S; Shimomura I; Behar S; Funahashi T
Arterioscler Thromb Vasc Biol; 2007 Mar; 27(3):635-41. PubMed ID: 17194889
[TBL] [Abstract][Full Text] [Related]
7. Effect of peroxisome proliferator-activated receptor alpha ligand fenofibrate on K(v) channels in the insulin-secreting cell line HIT-T15.
Shimomura K; Ikeda M; Ariyama Y; Proks P; Shimomura Y; Mori M; Matsumoto S
Gen Physiol Biophys; 2006 Dec; 25(4):455-60. PubMed ID: 17356236
[TBL] [Abstract][Full Text] [Related]
8. Regulation of human apoA-I by gemfibrozil and fenofibrate through selective peroxisome proliferator-activated receptor alpha modulation.
Duez H; Lefebvre B; Poulain P; Torra IP; Percevault F; Luc G; Peters JM; Gonzalez FJ; Gineste R; Helleboid S; Dzavik V; Fruchart JC; Fiévet C; Lefebvre P; Staels B
Arterioscler Thromb Vasc Biol; 2005 Mar; 25(3):585-91. PubMed ID: 15618549
[TBL] [Abstract][Full Text] [Related]
9. Fenofibrate prevents Rosiglitazone-induced body weight gain in ob/ob mice.
Carmona MC; Louche K; Nibbelink M; Prunet B; Bross A; Desbazeille M; Dacquet C; Renard P; Casteilla L; Pénicaud L
Int J Obes (Lond); 2005 Jul; 29(7):864-71. PubMed ID: 15917863
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-alpha by fenofibrate prevents myocardial dysfunction during endotoxemia in rats.
Jozefowicz E; Brisson H; Rozenberg S; Mebazaa A; Gelé P; Callebert J; Lebuffe G; Vallet B; Bordet R; Tavernier B
Crit Care Med; 2007 Mar; 35(3):856-63. PubMed ID: 17255874
[TBL] [Abstract][Full Text] [Related]
11. Fenofibrate, a peroxisome proliferator-activated receptor-alpha agonist, exerts anticonvulsive properties.
Porta N; Vallée L; Lecointe C; Bouchaert E; Staels B; Bordet R; Auvin S
Epilepsia; 2009 Apr; 50(4):943-8. PubMed ID: 19054409
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, exerts neuroprotective effects in traumatic brain injury.
Besson VC; Chen XR; Plotkine M; Marchand-Verrecchia C
Neurosci Lett; 2005 Nov; 388(1):7-12. PubMed ID: 16087294
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor alpha and gamma ligands inhibit the growth of human ovarian cancer.
Shigeto T; Yokoyama Y; Xin B; Mizunuma H
Oncol Rep; 2007 Oct; 18(4):833-40. PubMed ID: 17786343
[TBL] [Abstract][Full Text] [Related]
14. Sustained delivery of IL-1 Ra from biodegradable microspheres reduces the number of murine B16 melanoma lung metastases.
Lavi G; Voronov E; Dinarello CA; Apte RN; Cohen S
J Control Release; 2007 Nov; 123(2):123-30. PubMed ID: 17900737
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers.
Pós Z; Sáfrány G; Müller K; Tóth S; Falus A; Hegyesi H
Cancer Res; 2005 May; 65(10):4458-66. PubMed ID: 15899839
[TBL] [Abstract][Full Text] [Related]
16. Attenuation of cardiac dysfunction by a PPAR-alpha agonist is associated with down-regulation of redox-regulated transcription factors.
Ichihara S; Obata K; Yamada Y; Nagata K; Noda A; Ichihara G; Yamada A; Kato T; Izawa H; Murohara T; Yokota M
J Mol Cell Cardiol; 2006 Aug; 41(2):318-29. PubMed ID: 16806263
[TBL] [Abstract][Full Text] [Related]
17. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
[TBL] [Abstract][Full Text] [Related]
18. Age-related decrease in expression of peroxisome proliferator-activated receptor alpha and its effects on development of dyslipidemia.
Ye P; Wang ZJ; Zhang XJ; Zhao YL
Chin Med J (Engl); 2005 Jul; 118(13):1093-8. PubMed ID: 16098262
[TBL] [Abstract][Full Text] [Related]
19. Effects of simvastatin on the development of the atrial fibrillation substrate in dogs with congestive heart failure.
Shiroshita-Takeshita A; Brundel BJ; Burstein B; Leung TK; Mitamura H; Ogawa S; Nattel S
Cardiovasc Res; 2007 Apr; 74(1):75-84. PubMed ID: 17270161
[TBL] [Abstract][Full Text] [Related]
20. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
